InterCure Ltd. regained Nasdaq minimum bid compliance after its ordinary shares recorded a closing bid price of $1.00 per share or greater through September 4. The determination closed the delisting matter, giving investors confirmation that the Nasdaq listing requirement described in the notice had been satisfied.

Key Highlights

  • The applicable compliance period ended August 24 under Nasdaq Listing Rule 5810.
  • InterCure’s February 25 notification followed a period when its ordinary shares closed below $1.00 per share.
  • InterCure regained compliance after its ordinary shares recorded closing bid prices of at least $1.00 per share through September 4.
  • Nasdaq confirmed the compliance result on September 8.

InterCure Ltd. (NASDAQ: INCR) regained compliance with Nasdaq’s minimum bid price requirement after its ordinary shares recorded a closing bid price of $1.00 per share or greater through September 4. Nasdaq confirmed the result on September 8 and said the matter was closed.

Nasdaq Confirms $1.00 Bid Compliance

Nasdaq’s Listing Qualifications Department notified InterCure that the requirement under Listing Rule 5450(a)(1) had been met. The determination followed a February 25 notification stating that the ordinary shares had traded below $1.00 per share for a consecutive business-day period. Rule 5810 provided an applicable compliance period ending August 24. On September 8, Nasdaq confirmed that closing bids were at least $1.00 per share from August 24 through September 4.

Delisting Notice Matter Is Closed

The September 1 notice identified a direct listing consequence after InterCure failed to regain compliance within the applicable period. The September 8 determination confirmed that the price condition had been met and that InterCure had regained compliance with Rule 5450(a)(1). Nasdaq’s statement that the matter was closed is the stated resolution to the delisting notice for the ordinary shares.